Scientific progress in ACLF to be featured at The Liver Meeting® 2024, with 4 posters presenting new preclinical data, and 3 events bringing together key ACLF stakeholders Results from UNVEIL-IT® ...

Previously disclosed buy-backs 0 n.a. n.a.

(1) According to Art. 223- 11 of the AMF General Regulations the theoretical (or gross) number of voting rights is used on the basis of all shares with voting rights, including shares temporarily ...

accelerate field services capability and coverage in response to growing market demand from fleet customers.

556,500 shares in the Company, by way of donation/gift of 100% of the share capital in Sea Shell Enterprises Limited to members of his family. Following the transactions, Themistoklis Alafouzos will ...

compared to the same quarter last year to NOK 282.0 million, while adjusted EBITDA improved 14 percent to NOK 58.7 million. Spir Group’s real estate business area grew revenues by 15 percent, as ...

ABIVAX / Key word(s): Personnel Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax 13.11.2024 / 22:01 CET/CEST The issuer is solely responsible for ...

Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people ...

contingent resources of approximately 104 million barrels of oil and condensate and 215 billion cubic feet of gas. Panoro and GEPetrol have been awarded block EG-23 for an initial period of three ...

315,000,000 bonds 2024/2028 ISIN: NO0013220285 on Nordic ABM as of today. Attached is the Bond Terms, as well as the Admission Document and Loan Description prepared in connection with the listing.

Book-to-bill above 1 and sales organic growth around 5% aEBIT margin around 6.5% Free Cash Flow within the range €300 million to €500 million 13 November 2024 – In the first half of fiscal year ...

dividend distribution to shareholders of NOK 1.45 per share. Rana Gruber will host a physical event in Oslo to present its third quarter results and to provide a capital markets update on 13. November ...